Skip to main content

ADVERTISEMENT

Winston Wong, PharmD, Editor-in-Chief

Special Article
11/15/2019
Winston Wong, PharmD, Editor-in-Chief
Clinical pathways have become an integral part of oncology care. In use in oncology practices as early as the early 2000s, the prevalence of clinical pathways is expected to increase as the focus on value-based care...
Clinical pathways have become an integral part of oncology care. In use in oncology practices as early as the early 2000s, the prevalence of clinical pathways is expected to increase as the focus on value-based care...
...
11/15/2019
Journal of Clinical Pathways
Editor's Page
10/18/2019
Winston Wong, PharmD, Editor-in-Chief
Even though researchers are making progress every day, the precision medicine approach to cancer treatment is not yet part of routine care. Another strategy that can contribute to more personalized medicine is the...
Even though researchers are making progress every day, the precision medicine approach to cancer treatment is not yet part of routine care. Another strategy that can contribute to more personalized medicine is the...
Even...
10/18/2019
Journal of Clinical Pathways
Editor's Page
09/20/2019
Winston Wong, PharmD, Editor-in-Chief
*/ /*-->*/ The guidance that comes from clinical pathways encourages widespread and consistent evidence-based practice of medicine by incorporating the most up-to-date clinical guidelines with efficacy and,...
*/ /*-->*/ The guidance that comes from clinical pathways encourages widespread and consistent evidence-based practice of medicine by incorporating the most up-to-date clinical guidelines with efficacy and,...
...
09/20/2019
Journal of Clinical Pathways
Editor's Page
08/19/2019
Winston Wong, PharmD, Editor-in-Chief
Value assessment in oncology is an emerging area of interest, as demonstrated by the multiple value assessment tools launched in the last 5 years to help stakeholders analyze the efficacy, tolerability, and...
Value assessment in oncology is an emerging area of interest, as demonstrated by the multiple value assessment tools launched in the last 5 years to help stakeholders analyze the efficacy, tolerability, and...
Value...
08/19/2019
Journal of Clinical Pathways
Editor's Page
06/18/2019
Winston Wong, PharmD, Editor-in-Chief
Novel innovations in cell and gene therapies mark a new era in medicine whereby durable remission, and potentially cures, are within reach for several diseases. These advancements are clearly beneficial and have been...
Novel innovations in cell and gene therapies mark a new era in medicine whereby durable remission, and potentially cures, are within reach for several diseases. These advancements are clearly beneficial and have been...
Novel...
06/18/2019
Journal of Clinical Pathways
Editor's Page
05/15/2019
Winston Wong, PharmD, Editor-in-Chief
Many oncology practices have adopted clinical pathways over the last 5 years with varying degrees of success. These mixed results may stem from a lack of understanding or full commitment from practices in terms of...
Many oncology practices have adopted clinical pathways over the last 5 years with varying degrees of success. These mixed results may stem from a lack of understanding or full commitment from practices in terms of...
Many...
05/15/2019
Journal of Clinical Pathways
Editor's Page
04/16/2019
Winston Wong, PharmD, Editor-in-Chief
Clinical practice guidelines (CPGs) in oncology provide a collation of evidence-based, consensus-driven clinical treatment and management best practices to assist physicians in making difficult treatment decisions...
Clinical practice guidelines (CPGs) in oncology provide a collation of evidence-based, consensus-driven clinical treatment and management best practices to assist physicians in making difficult treatment decisions...
...
04/16/2019
Journal of Clinical Pathways
Editor's Page
03/14/2019
Winston Wong, PharmD, Editor-in-Chief
Continued innovations in oncology hold the promise of survival improvements. However, new treatments introduce significant challenges for patients, such as higher out-of-pocket expenses and new toxicities. Likewise,...
Continued innovations in oncology hold the promise of survival improvements. However, new treatments introduce significant challenges for patients, such as higher out-of-pocket expenses and new toxicities. Likewise,...
...
03/14/2019
Journal of Clinical Pathways
Editor's Page
02/19/2019
Winston Wong, PharmD, Editor-in-Chief
The delivery of cancer care is inevitably influenced by payment forces. In the ongoing transition from volume- to value-based payment, clinical pathways can serve as an integral tool for successful and streamlined...
The delivery of cancer care is inevitably influenced by payment forces. In the ongoing transition from volume- to value-based payment, clinical pathways can serve as an integral tool for successful and streamlined...
The...
02/19/2019
Journal of Clinical Pathways
Editor's Page
12/13/2018
Winston Wong, PharmD, Editor-in-Chief
As the US health care system continues to evolve to value-based care delivery and reimbursement, questions of how to determine what treatments and models produce the most value is imperative. Stakeholders need to...
As the US health care system continues to evolve to value-based care delivery and reimbursement, questions of how to determine what treatments and models produce the most value is imperative. Stakeholders need to...
As the...
12/13/2018
Journal of Clinical Pathways